Yufang Xiao

This inventor holds 30 USPTO granted patents and 7 published patent applications, plus 10 CIPO patents and 14 EPO patents, primarily in Protein Kinase Inhibitors. Top assignees: Merck Patent Gmbh, Vertex Pharmaceuticals, Inc.. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yufang Xiao. Retrieved from https://idiyas.com/inventor/yufang-xiao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 7)

% Patents Active = 53.3

CIPO Patents = 10 (Patent Applications = 11)

EPO Patents = 14 (Patent Applications = 24)

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 50(Granted Patents)

Location History:

Billerica, MA (US) (2023)
Lexington, MA (US) (2014 - 2024)

Company Filing History:

Vertex Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

Areas of Expertise:

GCN2 Inhibitors

SHP2 Antagonists

TBK/IKK Inhibitors

Heterocyclic Derivatives

Cyclic Amine Compounds

Aminopyrimidine Derivatives

Modulators of Kinase Activity

Neurodegenerative Diseases

Amino Azaheterocyclic Carboxamides

Quinoline Derivatives

Bicyclic Azaheterocyclic Carboxamides

Quinazoline Carboxamide Azetidines

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12084438 - GCN2 inhibitors and uses thereof (2024-09-10),

2. 11702392 - Pyrimidinone derivatives as SHP2 antagonists (2023-07-18),

3. 11440899 - Pyrimidine TBK/IKKe inhibitor compounds and uses thereof (2022-09-13),

4. 11001561 - Pyrimidinone derivatives as SHP2 antagonists (2021-05-11),

5. 10988477 - GCN2 inhibitors and uses thereof (2021-04-27),

6. 10793563 - GCN2 inhibitors and uses thereof (2020-10-06),

7. 10428080 - TBK/IKK inhibitor compounds and uses thereof (2019-10-01),

8. 10287300 - Heterocyclic derivatives as modulators of kinase activity (2019-05-14),

9. 10087166 - Cyclic amine azaheterocyclic carboxamides (2018-10-02),

10. 10080753 - Heterocyclic carboxamides as modulators of kinase activity (2018-09-25),

11. 10080750 - Aminopyrimidine derivatives for use as modulators of kinase activity (2018-09-25),

12. 9988391 - TBK/IKK inhibitor compounds and uses thereof (2018-06-05),

13. 9938268 - C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof (2018-04-10),

14. 9867826 - Heterocycles as modulators of kinase activity (2018-01-16),

15. 9850255 - Heterocyclic derivatives as modulators of kinase activity (2017-12-26),

Title: **Yufang Xiao: Innovator in Therapeutic Compounds**

Introduction

Yufang Xiao, based in Lexington, MA, is a prominent inventor known for his significant contributions to the field of therapeutic compounds, with an impressive portfolio of 30 patents. His work has garnered attention for its potential impact on the treatment of serious health conditions.

Latest Patents

Among his most recent inventions are novel compounds aimed at addressing critical health issues. One notable patent is focused on GCN2 inhibitors and their applications, offering innovative compounds and methods for their use. Another important patent involves pyrimidinone derivatives acting as SHP2 antagonists, which are detailed in the invention as effective for treating hyperproliferative diseases and disorders in mammals, particularly humans. These inventions reflect his commitment to advancing medical science through innovative solutions.

Career Highlights

Yufang Xiao has spent a significant part of his career at well-respected organizations like Merck Patent GmbH and Vertex Pharmaceuticals, Inc. His roles in these companies have allowed him to develop and refine his expertise in pharmaceutical innovations, contributing to his status as a leading inventor in the industry.

Collaborations

Collaboration has played a crucial role in Xiao's success, working alongside esteemed colleagues such as Bayard R. Huck and Xiaoling Chen. These partnerships have fostered a creative environment for discussing ideas and developing groundbreaking technologies.

Conclusion

Yufang Xiao stands out as a visionary inventor, dedicated to pushing the boundaries of medical treatment through his innovative patents. His work not only demonstrates his expertise but also holds potential for significant improvements in health care solutions.

Profile summary based on public USPTO records.